By Denny Jacob

MetLife on Wednesday said its board approved a $3 billion authorization for the company to repurchase its common stock.

The insurer said the new authorization is incremental to the $202 million remaining under its prior authorization from May 2022.

Write to Denny Jacob at denny.jacob@wsj.com

(END) Dow Jones Newswires

May 03, 2023 16:42 ET (20:42 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
MetLife (NYSE:MET)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more MetLife Charts.
MetLife (NYSE:MET)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more MetLife Charts.